BullFrog AI Holdings (BFRGW) Free Cash Flow (2022 - 2025)
BullFrog AI Holdings' (BFRGW) quarterly Free Cash Flow came in at -$1.2 million in Q4 2025, up 6.84% on a YoY basis from -$1.1 million in Q4 2024, and down 7.03% quarter-over-quarter from -$1.1 million in Q3 2025.
Analysis
BullFrog AI Holdings (BFRGW) Free Cash Flow (2022 - 2025) Analysis & Trends
BullFrog AI Holdings (BFRGW) has reported Free Cash Flow for 4 consecutive years, with -$1.2 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow rose 6.84% year-over-year to -$1.2 million; the trailing twelve-month figure through Dec 2025 stood at -$5.5 million (up 1.57% YoY), and the FY2025 full-year result was -$5.5 million, up 1.57% from the prior year.
- Free Cash Flow declined to -$1.2 million in Q4 2025 per BFRGW's latest filing, from -$1.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$9775.0 in Q1 2022 and bottomed at -$2.4 million in Q1 2023.
- Historically, Free Cash Flow has averaged -$1.1 million across 4 years, with a median of -$1.2 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Free Cash Flow sank 24056.89% in 2023, then rose 19.47% in 2024.
- Over 4 years, Free Cash Flow stood at -$39646.0 in 2022, then slumped by 2467.77% to -$1.0 million in 2023, then retreated by 24.95% to -$1.3 million in 2024, then grew by 6.84% to -$1.2 million in 2025.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$1.2 million, -$1.1 million, and -$1.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.04 Bn | 197.05 Bn | 7.24 Bn | 3.49 Bn |
| 2 | Gilead Sciences | 181.32 Bn | 178.14 Bn | 6.22 Bn | 3.43 Bn |
| 3 | Vertex Pharmaceuticals | 132.20 Bn | 124.35 Bn | 2.84 Bn | 1.01 Bn |
| 4 | Regeneron Pharmaceuticals | 82.41 Bn | 74.42 Bn | 3.93 Bn | 572.80 Mn |
| 5 | Argenx Se | 61.58 Bn | 56.39 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.71 Bn | 49.57 Bn | 52.00 Mn | -563.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.15 Bn | 30.84 Bn | 992.69 Mn | 292.04 Mn |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn | 408.00 Mn |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn | -268.64 Mn |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.18 Mn |
| Sep 30, 2025 | -1.11 Mn |
| Jun 30, 2025 | -1.43 Mn |
| Mar 31, 2025 | -1.80 Mn |
| Dec 31, 2024 | -1.27 Mn |
| Sep 30, 2024 | -1.21 Mn |
| Jun 30, 2024 | -1.23 Mn |
| Mar 31, 2024 | -1.90 Mn |
| Dec 31, 2023 | -1.02 Mn |
| Sep 30, 2023 | -1.39 Mn |
| Jun 30, 2023 | -1.23 Mn |
| Mar 31, 2023 | -2.36 Mn |
| Dec 31, 2022 | -39,646.00 |
| Sep 30, 2022 | -259,237.00 |
| Jun 30, 2022 | -602,232.00 |
| Mar 31, 2022 | -9,775.00 |